MedTrace Logo

CAYA Cancer Prospective Cohort Study

NCT07632014 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6000

Last updated 2026-06-08

No results posted yet for this study

Summary

Cancer is a leading cause of illness and death among children, adolescents, and young adults(CAYAs), especially in low- and middle-income countries(LMICs), where access to timely diagnosis and treatment is often limited. As a result, patients in these settings may experience higher rates of treatment complications, interruptions, and poorer outcomes compared with those in high-income countries (HICs).

This is a prospective, multicenter observational study that will follow children, adolescents, and young adults(CAYAs) with cancer who are receiving routine care at participating hospitals in low - and middle - income countries(LMICs). The study does not involve experimental treatments or changes to standard medical care. Information will be collected from medical records and from questionnaires that address access to care and social factors affecting treatment.

By describing treatment outcomes and the challenges patients and families face during cancer care, this study aims to provide data that can help inform future efforts to improve access to care and cancer outcomes in resource-limited settings.

Conditions

  • Cancer
  • Pediatric Cancer
  • Lymphoblastic Lymphoma (LBL)
  • Acute Lymphoblastic Leukemia (ALL)

Sponsors & Collaborators

  • Servier Affaires Médicales

    collaborator INDUSTRY

  • Resonance, Inc.

    lead OTHER

Eligibility

Min Age
0 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-11
Primary Completion
2032-11-11
Completion
2032-11-11

Countries

  • Armenia
  • Egypt
  • Guatemala

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07632014 on ClinicalTrials.gov